Isao Sakamoto

Executive Director(HQ)
President & CEO, Linical USA

Isao Sakamoto

Message

Since it was established in 2005, Linical has aimed at becoming a true strategic partner of pharmaceutical companies — a CDO (Contract Development Partner) — through quality and increased speed in new drug development. Thus far, we have helped many clients successfully develop new drugs to market. As a CRO, we have the important responsibility of scrupulously collecting accurate information and creating new data based on scientific grounds, all the while sharing the same vision and passion as the drug developers of pharmaceutical companies. Since we have continued to fulfill this responsibility faithfully, Linical has been able to expand globally, from Japan into Asia, and later into Europe and North America. We devote ourselves to offering our wealth of accumulated, proven expertise and reliability to an international market, so that we can become an indispensable force in pharmaceutical product development.